$PGEN
PRECIGEN, INC. Stock $pgen

$pgen Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000135609023000004 Filed on March 06, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.851M	$1.763M	$26.91M
YoY Change	-94.22%	-92.72%	-74.09%
Cost Of Revenue	$1.527M	$1.257M	$6.339M
YoY Change	-9.86%	-91.58%	-89.14%
Gross Profit	$324.0K	$506.0K	$20.57M
YoY Change	-91.52%	-94.56%	-54.78%
Gross Profit Margin	17.5%	28.7%	76.44%
Selling, General & Admin	$11.64M	$11.51M	$48.01M
YoY Change	-14.98%	-31.34%	-35.23%
% of Gross Profit	3592.28%	2274.7%	233.38%
Research & Development	$12.16M	$10.79M	$47.17M
YoY Change	3.07%	-17.1%	-5.93%
% of Gross Profit	3754.01%	2133.0%	229.31%
Depreciation & Amortization	$1.711M	$1.721M	$10.77M
YoY Change	-48.03%	-48.15%	-21.77%
% of Gross Profit	528.09%	340.12%	52.33%
Operating Expenses	$23.80M	$22.30M	$95.18M
YoY Change	-6.62%	-25.11%	-23.41%
Operating Profit	-$23.48M	-$21.80M	-$74.61M
YoY Change	8.34%	6.39%	-5.29%
Interest Expense	$309.0K	-$634.0K	-$5.779M
YoY Change	-115.44%	-86.14%	-66.55%
% of Operating Profit
Other Income/Expense, Net	$326.0K	$263.0K	$1.539M
YoY Change	64.65%	557.5%	-566.36%
Pretax Income	-$22.79M	-$22.17M	-$79.97M
YoY Change	18.02%	-11.4%	-17.5%
Income Tax	-$55.00K	$8.000K	-$189.0K
% Of Pretax Income
Net Earnings	-$22.73M	-$22.18M	$28.32M
YoY Change	18.09%	-11.42%	-130.72%
Net Earnings / Revenue	-1228.2%	-1257.86%	105.23%
Basic Earnings Per Share	-$0.10		$0.14
Diluted Earnings Per Share	-$0.10	-$0.11	$0.14
COMMON SHARES
Basic Shares Outstanding	252.2M shares	208.2M shares	200.4M shares
Diluted Shares Outstanding	229.8M shares		200.4M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$104.1M	$55.95M	$55.95M
YoY Change	-7.18%	-51.42%	-51.42%
Cash & Equivalents	$9.740M	$4.858M	$4.858M
Short-Term Investments	$94.35M	$51.09M	$51.09M
Other Short-Term Assets	$18.13M	$48.12M	$48.12M
YoY Change	248.72%	614.34%	614.34%
Inventory		$287.0K	$287.0K
Prepaid Expenses
Receivables	$1.771M	$959.0K	$978.0K
Other Receivables	$13.75M	$12.83M	$12.83M
Total Short-Term Assets	$137.7M	$118.2M	$118.2M
YoY Change	-11.1%	-24.56%	-24.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.908M	$7.329M	$15.42M
YoY Change	-79.43%	-14.77%	-65.91%
Goodwill	$36.97M	$36.92M
YoY Change	-31.05%	-1.68%
Intangibles	$43.85M	$44.46M
YoY Change	-14.74%	-14.99%
Long-Term Investments	$7.460M	$0.00	$0.00
YoY Change	-75.06%	-100.0%	-100.0%
Other Assets	$1.004M	$1.025M	$1.025M
YoY Change	-11.23%	9.51%	-13.72%
Total Long-Term Assets	$103.8M	$97.82M	$97.82M
YoY Change	-42.53%	-51.87%	-51.87%
TOTAL ASSETS
Total Short-Term Assets	$137.7M	$118.2M	$118.2M
Total Long-Term Assets	$103.8M	$97.82M	$97.82M
Total Assets	$241.5M	$216.0M	$216.0M
YoY Change	-28.02%	-39.98%	-39.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.809M	$4.068M	$4.068M
YoY Change	-13.73%	30.72%	-24.74%
Accrued Expenses	$29.09M	$31.33M	$31.33M
YoY Change	60.4%	28.58%	28.58%
Deferred Revenue	$15.00K	$25.00K
YoY Change	-99.44%	-98.32%
Short-Term Debt	$13.82M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$13.82M	$43.22M	$43.22M
YoY Change	3792.68%	83013.46%	10651.0%
Total Short-Term Liabilities	$46.73M	$78.65M	$78.65M
YoY Change	82.54%	127.0%	127.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Other Long-Term Liabilities	$8.441M	$8.810M	$8.810M
YoY Change	16782.0%	17520.0%	-72.95%
Total Long-Term Liabilities	$8.441M	$0.00	$8.810M
YoY Change	-95.8%	-100.0%	-95.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$46.73M	$78.65M	$78.65M
Total Long-Term Liabilities	$8.441M	$0.00	$8.810M
Total Liabilities	$57.41M	$89.72M	$89.72M
YoY Change	-78.06%	-64.47%	-64.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.891B	-$1.869B
YoY Change	-1.3%	-2.45%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$184.1M	$126.3M	$126.3M
YoY Change
Total Liabilities & Shareholders Equity	$241.5M	$216.0M	$216.0M
YoY Change	-28.02%	-39.98%	-39.98%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$22.73M	-$22.18M	$28.32M
YoY Change	18.09%	-11.42%	-130.72%
Depreciation, Depletion And Amortization	$1.711M	$1.721M	$10.77M
YoY Change	-48.03%	-48.15%	-21.77%
Cash From Operating Activities	-$18.39M	-$15.40M	-$65.05M
YoY Change	-2.1%	5.53%	16.63%
INVESTING ACTIVITIES
Capital Expenditures	$154.0K	$53.00K	$4.924M
YoY Change	-90.25%	-101.91%	-32.05%
Acquisitions
YoY Change
Other Investing Activities	-$50.25M	$11.47M	$231.3M
YoY Change	-376.93%	-38.65%	-443.78%
Cash From Investing Activities	-$50.41M	$11.42M	$226.4M
YoY Change	-404.25%	-28.3%	-403.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$29.27M		$154.7M
YoY Change	17747.56%		33098.5%
Cash From Financing Activities	$44.17M	-39.28M	-$155.3M
YoY Change	-27200.61%	35610.91%	-228.14%
NET CHANGE
Cash From Operating Activities	-$18.39M	-15.40M	-$65.05M
Cash From Investing Activities	-$50.41M	11.42M	$226.4M
Cash From Financing Activities	$44.17M	-39.28M	-$155.3M
Net Change In Cash	-$24.65M	-43.26M	$5.253M
YoY Change	845.17%	-3616.83%	-158.98%
FREE CASH FLOW
Cash From Operating Activities	-$18.39M	-$15.40M	-$65.05M
Capital Expenditures	$154.0K	$53.00K	$4.924M
Free Cash Flow	-$18.54M	-$15.45M	-$69.97M
YoY Change	-8.94%	30.75%	11.03%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001356090
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2022	dei	City Area Code CityAreaCode	301
CY2021	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetImpairmentCharges
CY2021	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetImpairmentCharges
CY2022	us-gaap	Impairment Long Lived Asset Held For Use Statement Of Income Or Comprehensive Income Extensible Enumeration ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssetImpairmentCharges
CY2018Q3	pgen	Share Lending Agreement Length Of Time For Shares To Be Returned Upon Termination ShareLendingAgreementLengthOfTimeForSharesToBeReturnedUponTermination	P5D
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-36042
CY2022	dei	Entity Registrant Name EntityRegistrantName	PRECIGEN, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0084895
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	20374 Seneca Meadows Parkway
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown,
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876
CY2022	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2022	dei	Local Phone Number LocalPhoneNumber	556-9900
CY2022	dei	Security12b Title Security12bTitle	Common Stock, No Par Value
CY2022	dei	Trading Symbol TradingSymbol	PGEN
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	162100000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	252194713	shares
CY2022	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Location AuditorLocation	Baltimore, Maryland
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4858000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36423000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	43339000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	51092000	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	72240000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	184000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	959000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1341000	usd
CY2022Q4	pgen	Related Party Receivable Allowancefor Credit Loss Current RelatedPartyReceivableAllowanceforCreditLossCurrent	0	usd
CY2021Q4	pgen	Related Party Receivable Allowancefor Credit Loss Current RelatedPartyReceivableAllowanceforCreditLossCurrent	1509000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	19000	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	73000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	12826000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	566000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	287000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	326000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4779000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5471000	usd
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	40188000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	118159000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	156628000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	48562000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7329000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8599000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44455000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	52291000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	36923000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	37554000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8086000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9990000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1025000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	936000	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	45296000	usd
CY2022Q4	us-gaap	Assets Assets	215977000	usd
CY2021Q4	us-gaap	Assets Assets	359856000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4068000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3112000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6377000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7856000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23747000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7817000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1490000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	43219000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	52000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1209000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1393000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	74000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	usd
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	12851000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	78645000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	34645000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	179882000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1818000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	23023000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6992000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8747000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2263000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2539000	usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	usd
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	3672000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	89718000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	252508000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	208150021	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	208150021	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	206739874	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	206739874	shares
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2021Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1998314000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2022701000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1868567000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1915556000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3488000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	203000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	126259000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	107348000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	215977000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	359856000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	108094000	usd
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	18641000	usd
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-66079000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	28317000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-92166000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-170521000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.40
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.40
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.56
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.56
CY2020	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.63
CY2020	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.63
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.54
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.54
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.09
CY2021	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.09
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.39
CY2020	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.39
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	200360821	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	200360821	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	197759900	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	197759900	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	167065539	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	167065539	shares
CY2022	us-gaap	Profit Loss ProfitLoss	28317000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-92166000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-170521000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-431000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-344000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	6000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-3262000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-3450000	usd
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	4502000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-26957000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	24624000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-95960000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-139056000	usd
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	71711000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18366000	usd
CY2020	pgen	Stock Issued During Period Value Restricted Stock Awards Vestedand Stock Optionsand Warrants Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedandStockOptionsandWarrantsExercised	117000	usd
CY2020	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	5100000	usd
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1006000	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	35000000	usd
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	56827000	usd
CY2020	pgen	Stock Issued During Period In Conjunction With Settlement Agreement Value New Issues StockIssuedDuringPeriodInConjunctionWithSettlementAgreementValueNewIssues	18103000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-170521000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-26957000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4508000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	67174000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	67174000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13904000	usd
CY2021	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	608000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	577000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	121045000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-92166000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3794000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	107348000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	107348000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10207000	usd
CY2022	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	1000	usd
CY2022	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	1698000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	575000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	28317000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-3691000	usd
CY2022	pgen	Disposal Group Including Discontinued Operation Gain Losson Disposal DisposalGroupIncludingDiscontinuedOperationGainLossonDisposal	94702000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	126259000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	28317000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-92166000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-170521000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10765000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13761000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17516000	usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-421000	usd
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-150000	usd
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-4442000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	482000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	9635000	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	638000	usd
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	543000	usd
CY2020	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	13326000	usd
CY2021	pgen	Disposal Group Including Discontinued Operation Gain Losson Disposal DisposalGroupIncludingDiscontinuedOperationGainLossonDisposal	0	usd
CY2020	pgen	Disposal Group Including Discontinued Operation Gain Losson Disposal DisposalGroupIncludingDiscontinuedOperationGainLossonDisposal	672000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	0	usd
CY2021	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	0	usd
CY2020	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	-26957000	usd
CY2022	pgen	Gain Loss Related To Noncash Litigation Settlement GainLossRelatedToNoncashLitigationSettlement	0	usd
CY2021	pgen	Gain Loss Related To Noncash Litigation Settlement GainLossRelatedToNoncashLitigationSettlement	0	usd
CY2020	pgen	Gain Loss Related To Noncash Litigation Settlement GainLossRelatedToNoncashLitigationSettlement	-11436000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	961000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	pgen	Equity Securitiesand Preferred Stock Unrealizedand Realized Appreciation Depreciation EquitySecuritiesandPreferredStockUnrealizedandRealizedAppreciationDepreciation	0	usd
CY2021	pgen	Equity Securitiesand Preferred Stock Unrealizedand Realized Appreciation Depreciation EquitySecuritiesandPreferredStockUnrealizedandRealizedAppreciationDepreciation	0	usd
CY2020	pgen	Equity Securitiesand Preferred Stock Unrealizedand Realized Appreciation Depreciation EquitySecuritiesandPreferredStockUnrealizedandRealizedAppreciationDepreciation	-106000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-832000	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1232000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-150000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-167000	usd
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	699000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	862000	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-3000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1176000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	10206000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	13904000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	18366000	usd
CY2022	pgen	Shares Issued During Period Value Issued For Services Expense SharesIssuedDuringPeriodValueIssuedForServicesExpense	576000	usd
CY2021	pgen	Shares Issued During Period Value Issued For Services Expense SharesIssuedDuringPeriodValueIssuedForServicesExpense	577000	usd
CY2020	pgen	Shares Issued During Period Value Issued For Services Expense SharesIssuedDuringPeriodValueIssuedForServicesExpense	1006000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	944000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1268000	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	899000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1042000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	11735000	usd
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	10587000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-156000	usd
CY2022	pgen	Noncash Gain Loss On Termination Of Lease NoncashGainLossOnTerminationOfLease	0	usd
CY2021	pgen	Noncash Gain Loss On Termination Of Lease NoncashGainLossOnTerminationOfLease	5831000	usd
CY2020	pgen	Noncash Gain Loss On Termination Of Lease NoncashGainLossOnTerminationOfLease	-191000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-106000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-24000	usd
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-35000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2229000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6176000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2214000	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-54000	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	54000	usd
CY2020	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-258000	usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	11338000	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	330000	usd
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-1853000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2341000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1903000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2511000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-289000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-520000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	812000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	101000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-305000	usd
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	142000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	379000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	420000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1097000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-37000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	2853000	usd
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-789000	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	11561000	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1850000	usd
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-2682000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-23396000	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1656000	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-21045000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-107000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	97000	usd
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-887000	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-78000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	8000	usd
CY2020	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-33000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-37000	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-50000	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-65045000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55771000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77021000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	174221000	usd
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	171360000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	68441000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	100168000	usd
CY2020	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	133000000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4924000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7247000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7527000	usd
CY2022	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	594000	usd
CY2021	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	3006000	usd
CY2020	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	6484000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	162306000	usd
CY2021	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
CY2020	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	64240000	usd
CY2022	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	0	usd
CY2021	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	3754000	usd
CY2020	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	2942000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	226417000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-74540000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27779000	usd
CY2022	pgen	Proceedsfrom Issuanceof Common Stockand Warrants Net ProceedsfromIssuanceofCommonStockandWarrantsNet	0	usd
CY2021	pgen	Proceedsfrom Issuanceof Common Stockand Warrants Net ProceedsfromIssuanceofCommonStockandWarrantsNet	121045000	usd
CY2020	pgen	Proceedsfrom Issuanceof Common Stockand Warrants Net ProceedsfromIssuanceofCommonStockandWarrantsNet	35000000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10005000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	11927000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	154705000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	466000	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	490000	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	588000	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	pgen	Proceedsfrom Stock Optionsand Warrants Exercised ProceedsfromStockOptionsandWarrantsExercised	1000	usd
CY2021	pgen	Proceedsfrom Stock Optionsand Warrants Exercised ProceedsfromStockOptionsandWarrantsExercised	608000	usd
CY2020	pgen	Proceedsfrom Stock Optionsand Warrants Exercised ProceedsfromStockOptionsandWarrantsExercised	117000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-155292000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	121187000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32705000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-827000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	217000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	353000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5253000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8907000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16184000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43343000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52250000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	68434000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48596000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43343000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52250000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	8535000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	7155000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	7202000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	36000	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	48000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2020	us-gaap	Stock Issued1 StockIssued1	56827000	usd
CY2022	pgen	Stock Issued Settlement Agreement StockIssuedSettlementAgreement	0	usd
CY2021	pgen	Stock Issued Settlement Agreement StockIssuedSettlementAgreement	0	usd
CY2020	pgen	Stock Issued Settlement Agreement StockIssuedSettlementAgreement	18103000	usd
CY2022	pgen	Accrued Compensation Paidin Equity Awards AccruedCompensationPaidinEquityAwards	1698000	usd
CY2021	pgen	Accrued Compensation Paidin Equity Awards AccruedCompensationPaidinEquityAwards	0	usd
CY2020	pgen	Accrued Compensation Paidin Equity Awards AccruedCompensationPaidinEquityAwards	5100000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	40000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	820000	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	277000	usd
CY2022	pgen	Sale Of Assets Included In Receivables SaleOfAssetsIncludedInReceivables	0	usd
CY2021	pgen	Sale Of Assets Included In Receivables SaleOfAssetsIncludedInReceivables	14000	usd
CY2020	pgen	Sale Of Assets Included In Receivables SaleOfAssetsIncludedInReceivables	4227000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4858000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36423000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	43339000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	usd
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	6497000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	399000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	423000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48596000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43343000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-79777000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1868567000	usd
CY2022	pgen	Collaboration Agreement Termination Notice Period CollaborationAgreementTerminationNoticePeriod	P90D
CY2022Q4	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	19909000	usd
CY2021Q4	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	22301000	usd
CY2022	pgen	Highly Liquid Investment Maximum Maturity Period HighlyLiquidInvestmentMaximumMaturityPeriod	P3M
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	2985000	usd
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	20697000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	43339000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:13pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Due to the Company's fixed rate securities holdings, the Company's investment portfolio is susceptible to changes in interest rates. As of December 31, 2022, gross unrealized losses on the Company's short-term investments were not material. From time </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">to time, the Company may liquidate some or all of its investments to fund operational needs or other activities, such as capital expenditures or business acquisitions, or distribute its equity securities to shareholders as a stock dividend. Although the Company has no intent to liquidate such investments, depending on which investments the Company liquidates to fund these activities, the Company could recognize a portion, or all, of the gross unrealized losses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of trade and related party receivables. The Company manages credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs ongoing credit evaluations of its customers but generally does not require collateral to support accounts receivable.</span></div>
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15899091	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12850556	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13116872	shares
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2022	pgen	Interest Expense Debt Amortizationof Debt Discount Premiumand Debt Issuance Costs InterestExpenseDebtAmortizationofDebtDiscountPremiumandDebtIssuanceCosts	11800000	usd
CY2022Q3	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	162306000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1843000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24513000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1490000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1818000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	23023000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1843000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24513000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	51852000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	760000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	51092000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	121133000	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	331000	usd
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	120802000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	51092000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	51092000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	51092000	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	120802000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	287000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	326000	usd
CY2022Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	164000	usd
CY2021Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	164000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2592000	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2592000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	457000	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	434000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18006000	usd
CY2021Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	16812000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4333000	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3366000	usd
CY2022Q4	pgen	Breedingand Production Animals Gross BreedingandProductionAnimalsGross	123000	usd
CY2021Q4	pgen	Breedingand Production Animals Gross BreedingandProductionAnimalsGross	36000	usd
CY2022Q4	pgen	Computer Hardwareand Software ComputerHardwareandSoftware	4562000	usd
CY2021Q4	pgen	Computer Hardwareand Software ComputerHardwareandSoftware	4823000	usd
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	531000	usd
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1829000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30768000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	30056000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23439000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21457000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7329000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8599000	usd
CY2022	us-gaap	Depreciation Depreciation	2393000	usd
CY2021	us-gaap	Depreciation Depreciation	2866000	usd
CY2020	us-gaap	Depreciation Depreciation	3049000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	638000	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	543000	usd
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	814000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	14483000	usd
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	14001000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	482000	usd
CY2022	pgen	Number Of Reporting Units Impaired NumberOfReportingUnitsImpaired	1	reporting_unit
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	82692000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	38237000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44455000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	86973000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	34682000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	52291000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4798000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5273000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5243000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4773000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4773000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4773000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4773000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4773000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	20590000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	44455000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	43219000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	179934000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	43219000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	52000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	179882000	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	200000000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	759000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	43340000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	43340000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-79966000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110967000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-104524000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	37000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	37000	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	37000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-39000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	7000	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	74000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-198000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-215000	usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-204000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	11000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	11000	usd
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	11000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-189000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-160000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-82000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-16793000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23303000	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-21950000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2884000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-4670000	usd
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-5199000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	179000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	832000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	5709000	usd
CY2022	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Officers Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficersCompensation	263000	usd
CY2021	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Officers Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficersCompensation	1459000	usd
CY2020	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Officers Compensation EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOfficersCompensation	728000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	101000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2022	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Equity Investment Loss EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInvestmentLoss	3093000	usd
CY2021	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Equity Investment Loss EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInvestmentLoss	0	usd
CY2020	pgen	Effective Income Tax Rate Reconciliation Nondeductible Expense Equity Investment Loss EffectiveIncomeTaxRateReconciliationNondeductibleExpenseEquityInvestmentLoss	0	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	991000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	958000	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	524000	usd
CY2022	pgen	Effective Income Tax Rate Reconciliation Acquisitionrelated Transaction Costs EffectiveIncomeTaxRateReconciliationAcquisitionrelatedTransactionCosts	0	usd
CY2021	pgen	Effective Income Tax Rate Reconciliation Acquisitionrelated Transaction Costs EffectiveIncomeTaxRateReconciliationAcquisitionrelatedTransactionCosts	0	usd
CY2020	pgen	Effective Income Tax Rate Reconciliation Acquisitionrelated Transaction Costs EffectiveIncomeTaxRateReconciliationAcquisitionrelatedTransactionCosts	0	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	18000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-32000	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-21000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	533000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-46000	usd
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-306000	usd
CY2022	pgen	Income Tax Reconciliation Income Tax Expense Benefit Before Valuation Allowance IncomeTaxReconciliationIncomeTaxExpenseBenefitBeforeValuationAllowance	-16481000	usd
CY2021	pgen	Income Tax Reconciliation Income Tax Expense Benefit Before Valuation Allowance IncomeTaxReconciliationIncomeTaxExpenseBenefitBeforeValuationAllowance	-26718000	usd
CY2020	pgen	Income Tax Reconciliation Income Tax Expense Benefit Before Valuation Allowance IncomeTaxReconciliationIncomeTaxExpenseBenefitBeforeValuationAllowance	-21563000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	16292000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	26558000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	21481000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-189000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-160000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-82000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	53000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1506000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	370000	usd
CY2022Q4	pgen	Deferred Tax Asset Equity Method Investmentsand Investments Accounted For Under The Fair Value Option DeferredTaxAssetEquityMethodInvestmentsandInvestmentsAccountedForUnderTheFairValueOption	258000	usd
CY2021Q4	pgen	Deferred Tax Asset Equity Method Investmentsand Investments Accounted For Under The Fair Value Option DeferredTaxAssetEquityMethodInvestmentsandInvestmentsAccountedForUnderTheFairValueOption	570000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	284000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	69807000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	80540000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3219000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3090000	usd
CY2022Q4	pgen	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	2182000	usd
CY2021Q4	pgen	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	2839000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	17106000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	15227000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	474000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	7300000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	16318000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	12160000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	11168000	usd
CY2022Q4	pgen	Deferred Tax Assets Operating Capital Loss And Interest Expense Carryforwards DeferredTaxAssetsOperatingCapitalLossAndInterestExpenseCarryforwards	288397000	usd
CY2021Q4	pgen	Deferred Tax Assets Operating Capital Loss And Interest Expense Carryforwards DeferredTaxAssetsOperatingCapitalLossAndInterestExpenseCarryforwards	301791000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	410258000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	424401000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	401086000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	408396000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	9172000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	16005000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	250000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2071000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2735000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	9364000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	10861000	usd
CY2022Q4	pgen	Deferred Tax Liabilities Equity Componentof Long Term Debt DeferredTaxLiabilitiesEquityComponentofLongTermDebt	0	usd
CY2021Q4	pgen	Deferred Tax Liabilities Equity Componentof Long Term Debt DeferredTaxLiabilitiesEquityComponentofLongTermDebt	4698000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	11435000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	18544000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2263000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2539000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	408396000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	387348000	usd
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	349008000	usd
CY2022	pgen	Valuation Allowance Deferred Tax Asset Deconsolidation ValuationAllowanceDeferredTaxAssetDeconsolidation	0	usd
CY2021	pgen	Valuation Allowance Deferred Tax Asset Deconsolidation ValuationAllowanceDeferredTaxAssetDeconsolidation	0	usd
CY2020	pgen	Valuation Allowance Deferred Tax Asset Deconsolidation ValuationAllowanceDeferredTaxAssetDeconsolidation	0	usd
CY2022	pgen	Valuation Allowance Deferred Tax Assets Establishment Of Deferred Taxes For Subsidiaries Included In Discontinued Operations ValuationAllowanceDeferredTaxAssetsEstablishmentOfDeferredTaxesForSubsidiariesIncludedInDiscontinuedOperations	0	usd
CY2021	pgen	Valuation Allowance Deferred Tax Assets Establishment Of Deferred Taxes For Subsidiaries Included In Discontinued Operations ValuationAllowanceDeferredTaxAssetsEstablishmentOfDeferredTaxesForSubsidiariesIncludedInDiscontinuedOperations	0	usd
CY2020	pgen	Valuation Allowance Deferred Tax Assets Establishment Of Deferred Taxes For Subsidiaries Included In Discontinued Operations ValuationAllowanceDeferredTaxAssetsEstablishmentOfDeferredTaxesForSubsidiariesIncludedInDiscontinuedOperations	0	usd
CY2022	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Current Year Operations ValuationAllowanceDeferredTaxAssetChangeInAmountCurrentYearOperations	16292000	usd
CY2021	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Current Year Operations ValuationAllowanceDeferredTaxAssetChangeInAmountCurrentYearOperations	26558000	usd
CY2020	pgen	Valuation Allowance Deferred Tax Asset Change In Amount Current Year Operations ValuationAllowanceDeferredTaxAssetChangeInAmountCurrentYearOperations	21481000	usd
CY2022	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations Treated As Asset Sales ValuationAllowanceDeferredTaxAssetsDiscontinuedOperationsTreatedAsAssetSales	-27909000	usd
CY2021	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations Treated As Asset Sales ValuationAllowanceDeferredTaxAssetsDiscontinuedOperationsTreatedAsAssetSales	-3626000	usd
CY2020	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations Treated As Asset Sales ValuationAllowanceDeferredTaxAssetsDiscontinuedOperationsTreatedAsAssetSales	7805000	usd
CY2022	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations ValuationAllowanceDeferredTaxAssetsDiscontinuedOperations	0	usd
CY2021	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations ValuationAllowanceDeferredTaxAssetsDiscontinuedOperations	-1186000	usd
CY2020	pgen	Valuation Allowance Deferred Tax Assets Discontinued Operations ValuationAllowanceDeferredTaxAssetsDiscontinuedOperations	8019000	usd
CY2022	pgen	Valuation Allowance Deferred Tax Asset Change In Foreign Currency Translation Adjustment ValuationAllowanceDeferredTaxAssetChangeInForeignCurrencyTranslationAdjustment	-391000	usd
CY2021	pgen	Valuation Allowance Deferred Tax Asset Change In Foreign Currency Translation Adjustment ValuationAllowanceDeferredTaxAssetChangeInForeignCurrencyTranslationAdjustment	-698000	usd
CY2020	pgen	Valuation Allowance Deferred Tax Asset Change In Foreign Currency Translation Adjustment ValuationAllowanceDeferredTaxAssetChangeInForeignCurrencyTranslationAdjustment	1035000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	401086000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	408396000	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	387348000	usd
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	17250000	shares
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	121045000	usd
CY2018Q3	us-gaap	Ownshare Lending Arrangement Shares Issued OwnshareLendingArrangementSharesIssued	7479431	shares
CY2018Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	13.37
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10206000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13904000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18366000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward	ten
CY2022	pgen	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P1Y
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2444000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	2872000	usd
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	3239000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	170000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	252000	usd
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	311000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	422000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	800000	usd
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	842000	usd
CY2022	us-gaap	Lease Cost LeaseCost	3036000	usd
CY2021	us-gaap	Lease Cost LeaseCost	3924000	usd
CY2020	us-gaap	Lease Cost LeaseCost	4392000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2074000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1882000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1851000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1508000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1246000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3108000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11669000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3468000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8201000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1209000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6992000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8201000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M2D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M19D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1105
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1094
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2493000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3199000	usd
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	3679000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	466000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4868000	usd
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	112000	usd
CY2022	pgen	Net Income Loss Attributableto Parent Adjusted Ebitda Including Cash Paidfor Capital Expendituresand Investmentsin Affiliates NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates	-40042000	usd
CY2021	pgen	Net Income Loss Attributableto Parent Adjusted Ebitda Including Cash Paidfor Capital Expendituresand Investmentsin Affiliates NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates	-38856000	usd
CY2020	pgen	Net Income Loss Attributableto Parent Adjusted Ebitda Including Cash Paidfor Capital Expendituresand Investmentsin Affiliates NetIncomeLossAttributabletoParentAdjustedEBITDAIncludingCashPaidforCapitalExpendituresandInvestmentsinAffiliates	-31374000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-79966000	usd
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	397000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110967000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-104524000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26909000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14267000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	31992000	usd
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-215000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	37554000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-149000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	482000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	36923000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	564000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	388000	usd

Files In Submission

Name	View Source	Status
pgen-20221231_cal.xml	Edgar Link	unprocessable
0001356090-23-000004-index-headers.html	Edgar Link	pending
0001356090-23-000004-index.html	Edgar Link	pending
0001356090-23-000004.txt	Edgar Link	pending
0001356090-23-000004-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pgen-20221231.htm	Edgar Link	pending
pgen-20221231.xsd	Edgar Link	pending
pgen-20221231xexx211.htm	Edgar Link	pending
pgen-20221231xexx231.htm	Edgar Link	pending
pgen-20221231xexx311.htm	Edgar Link	pending
pgen-20221231xexx312.htm	Edgar Link	pending
pgen-20221231xexx321.htm	Edgar Link	pending
pgen-20221231xexx322.htm	Edgar Link	pending
pgen-20221231_g1.jpg	Edgar Link	pending
pgen-20221231_g10.jpg	Edgar Link	pending
pgen-20221231_g11.jpg	Edgar Link	pending
pgen-20221231_g12.jpg	Edgar Link	pending
pgen-20221231_g13.jpg	Edgar Link	pending
pgen-20221231_g14.jpg	Edgar Link	pending
pgen-20221231_g15.jpg	Edgar Link	pending
pgen-20221231_g16.jpg	Edgar Link	pending
pgen-20221231_g17.jpg	Edgar Link	pending
pgen-20221231_g18.jpg	Edgar Link	pending
pgen-20221231_g19.jpg	Edgar Link	pending
pgen-20221231_g2.jpg	Edgar Link	pending
pgen-20221231_g20.jpg	Edgar Link	pending
pgen-20221231_g21.jpg	Edgar Link	pending
pgen-20221231_g22.jpg	Edgar Link	pending
pgen-20221231_g23.jpg	Edgar Link	pending
pgen-20221231_g24.jpg	Edgar Link	pending
pgen-20221231_g3.jpg	Edgar Link	pending
pgen-20221231_g4.jpg	Edgar Link	pending
pgen-20221231_g5.jpg	Edgar Link	pending
pgen-20221231_g6.jpg	Edgar Link	pending
pgen-20221231_g7.jpg	Edgar Link	pending
pgen-20221231_g8.jpg	Edgar Link	pending
pgen-20221231_g9.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
pgen-20221231_def.xml	Edgar Link	unprocessable
pgen-20221231_pre.xml	Edgar Link	unprocessable
pgen-20221231_lab.xml	Edgar Link	unprocessable
pgen-20221231_htm.xml	Edgar Link	completed
R106.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PGEN
PRECIGEN, INC. Stock $pgen

2023 Q1 Form 10-K Financial Statement

#000135609023000004 Filed on March 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGEN PRECIGEN, INC. Stock $pgen

2023 Q1 Form 10-K Financial Statement

#000135609023000004 Filed on March 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGEN
PRECIGEN, INC. Stock $pgen